Original Research
Accepted on 13 May 2025
Integrated pan-cancer analysis of ADM's role in prognosis, immune modulation and resistance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1573250
Type at least 3 characters
7,709 articles
Case Report
Accepted on 13 May 2025
Treatment strategies for rapid recurrence and progression after surgery for stage I pulmonary pleomorphic carcinoma: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1547872
Original Research
Accepted on 13 May 2025
Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1553882
Original Research
Accepted on 13 May 2025
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571508
Original Research
Accepted on 13 May 2025
The Landscape and Clinical Impact of Tumor-Associated Macrophages and PD-L1 in Primary Breast Cancers and their Brain Metastases
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1598293
Systematic Review
Published on 13 May 2025
Elevated platelet-to-lymphocyte ratio predicts poor clinical outcomes in non-muscle invasive bladder cancer: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1578069
- 118 views
Mini Review
Published on 13 May 2025
Ultrasound-assisted immunotherapy for malignant tumour
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1547594
- 159 views
Systematic Review
Published on 13 May 2025
Antibody-drug conjugates as game changers in bladder cancer: current progress and future directions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1591191
Original Research
Published on 13 May 2025
Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1574434
- 172 views
Original Research
Published on 13 May 2025
Glypican-3 regulated epithelial mesenchymal transformation-related genes in osteosarcoma: based on comprehensive tumor microenvironment profiling
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1566061
- 105 views
Mini Review
Published on 13 May 2025
The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1573576
Systematic Review
Published on 13 May 2025
Tracing the history of clinical practice of liquid biopsy: a bibliometric analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1574736
Original Research
Published on 13 May 2025
IL-6 is a prognostic biomarker in patients with advanced esophageal squamous cell carcinoma received with PD-1 inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1569042
- 103 views
Original Research
Published on 13 May 2025
Potentiating T cell tumor targeting using a combination of TCR with a Siglec-7 based CSR
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1536868
- 111 views
Original Research
Published on 13 May 2025
Cost-effectiveness analysis of first-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1575627
- 175 views
Original Research
Published on 13 May 2025
HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546939
- 199 views